Angiodynamics (ANGO) Acquisitions (2012 - 2024)

Angiodynamics' (ANGO) quarterly Acquisitions came in at $3.2 million in Q1 2024, up 501.85% on a QoQ basis from $540000.0 in Q4 2022.

Angiodynamics (ANGO) Acquisitions (2012 - 2024) Analysis & Trends

Angiodynamics (ANGO) has 11 years of Acquisitions data on file, last reported at $3.2 million in Q1 2024.

Quarterly Acquisitions changed N/A year-over-year to $3.2 million in Q1 2024, while the trailing twelve-month figure through Feb 2024 was $3.8 million (up 601.85% YoY) and the FY2012 annual result came in at $237.9 million, up 21803.04% from the prior year.
Acquisitions rose to $3.2 million in Q1 2024, from $540000.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $10.0 million in Q1 2020 to a low of $540000.0 in Q4 2022.
A 4-year average of $4.3 million and a median of $3.4 million in 2021 frame the typical range for Acquisitions.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	-
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	22.00 Mn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	-
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	325.32 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	-
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	-
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	-
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	-
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	-
10	Angiodynamics	655.49 Mn	601.62 Mn	46.77 Mn	-

Download Data